R&D Catching the signals sooner: AI’s role in proactive pharmaco... AI is not a replacement for medical judgement. Rather, it enables a human-guided, scientifically grounded approach.
News Insmed partners patient group on bronchiectasis study Insmed is working with a bronchiectasis patient organisation on a real-world trial of Brinsupri, the first FDA-approved drug for the lung disorder.
Market Access HES data: The UK’s powerful source of real-world evidence HES data not only supports the effective management of health and care services, but it can also power clinical research and innovation.
News ESC: Real-world study gives Wegovy edge over Lilly rival Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy works better than Eli Lilly's fast-growing rival Zepbound.
News Leaked MAHA draft signposts US health reform under Trump A leaked version of the Make America Healthy Again programme for the Trump administration has plenty for the pharma industry to stew over.
R&D From data to impact: How real-world evidence will transform ... Real-world evidence (RWE) has moved from the periphery to the centre of how healthcare decisions are made.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.